Low Molecular Weight Heparin (LMWHs) Market Report

Global and Region Low Molecular Weight Heparin (LMWHs) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：232
  • REPORT CODE：GMM968799
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Low Molecular Weight Heparin (LMWHs) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Low Molecular Weight Heparin (LMWHs)market, defines the market attractiveness level of Low Molecular Weight Heparin (LMWHs) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Low Molecular Weight Heparin (LMWHs) industry, describes the types of Low Molecular Weight Heparin (LMWHs) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Low Molecular Weight Heparin (LMWHs) market and the development prospects and opportunities of Low Molecular Weight Heparin (LMWHs) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Low Molecular Weight Heparin (LMWHs) market in Chapter 13.

    By Player:

    • Opocrin

    • Leo

    • Techdow

    • Pfizer

    • Amphastar

    • Sandoz

    • Glaxo Smith Kline

    • CSBIO

    • Sanofi-aventis

    • Aspen

    • Bioibérica

    • Teva

    • Abbott Laboratories

    • Intrapharm

    By Type:

    • Enoxaparin

    • Dalteparin

    • Tinzaparin

    • Fraxiparine

    By End-User:

    • Treatment of Venous Thromboembolism

    • Complications of Pregnancy

    • Cardioversion of Atrial Fibrillation/Flutter

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Low Molecular Weight Heparin (LMWHs) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Low Molecular Weight Heparin (LMWHs) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Low Molecular Weight Heparin (LMWHs) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Low Molecular Weight Heparin (LMWHs) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Low Molecular Weight Heparin (LMWHs) Market Analysis and Outlook to 2022

    • 7.1 Global Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    • 7.2 United States Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    • 7.3 Europe Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    • 7.4 China Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    • 7.5 Japan Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    • 7.6 India Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    • 7.7 South Korea Low Molecular Weight Heparin (LMWHs) Consumption (2017-2022)

    8 Region and Country-wise Low Molecular Weight Heparin (LMWHs) Market Analysis and Outlook to 2028

    • 8.1 Global Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    • 8.2 United States Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    • 8.3 Europe Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    • 8.4 China Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    • 8.5 Japan Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    • 8.6 India Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    • 8.7 South Korea Low Molecular Weight Heparin (LMWHs) Consumption Forecast (2022-2028)

    9 Global Low Molecular Weight Heparin (LMWHs) Market Outlook by Types and Applications to 2022

    • 9.1 Global Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Enoxaparin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dalteparin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Tinzaparin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Fraxiparine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Treatment of Venous Thromboembolism Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Complications of Pregnancy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardioversion of Atrial Fibrillation/Flutter Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Low Molecular Weight Heparin (LMWHs) Market Outlook by Types and Applications to 2028

    • 10.1 Global Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Enoxaparin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dalteparin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Tinzaparin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Fraxiparine Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Treatment of Venous Thromboembolism Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Complications of Pregnancy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cardioversion of Atrial Fibrillation/Flutter Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Low Molecular Weight Heparin (LMWHs) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Low Molecular Weight Heparin (LMWHs) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Low Molecular Weight Heparin (LMWHs) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Low Molecular Weight Heparin (LMWHs) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Low Molecular Weight Heparin (LMWHs) Market Competitive Analysis

    • 14.1 Opocrin

      • 14.1.1 Opocrin Company Details

      • 14.1.2 Opocrin Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Opocrin Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.2 Leo

      • 14.2.1 Leo Company Details

      • 14.2.2 Leo Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Leo Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.3 Techdow

      • 14.3.1 Techdow Company Details

      • 14.3.2 Techdow Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Techdow Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.5 Amphastar

      • 14.5.1 Amphastar Company Details

      • 14.5.2 Amphastar Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Amphastar Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.6 Sandoz

      • 14.6.1 Sandoz Company Details

      • 14.6.2 Sandoz Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sandoz Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.7 Glaxo Smith Kline

      • 14.7.1 Glaxo Smith Kline Company Details

      • 14.7.2 Glaxo Smith Kline Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Glaxo Smith Kline Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.8 CSBIO

      • 14.8.1 CSBIO Company Details

      • 14.8.2 CSBIO Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 CSBIO Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.9 Sanofi-aventis

      • 14.9.1 Sanofi-aventis Company Details

      • 14.9.2 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.10 Aspen

      • 14.10.1 Aspen Company Details

      • 14.10.2 Aspen Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Aspen Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.11 Bioibérica

      • 14.11.1 Bioibérica Company Details

      • 14.11.2 Bioibérica Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bioibérica Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.12 Teva

      • 14.12.1 Teva Company Details

      • 14.12.2 Teva Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Teva Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.13 Abbott Laboratories

      • 14.13.1 Abbott Laboratories Company Details

      • 14.13.2 Abbott Laboratories Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Abbott Laboratories Low Molecular Weight Heparin (LMWHs) Product and Service

    • 14.14 Intrapharm

      • 14.14.1 Intrapharm Company Details

      • 14.14.2 Intrapharm Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Intrapharm Low Molecular Weight Heparin (LMWHs) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Low Molecular Weight Heparin (LMWHs)

    • Figure Low Molecular Weight Heparin (LMWHs) Picture

    • Table Global Low Molecular Weight Heparin (LMWHs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Low Molecular Weight Heparin (LMWHs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Low Molecular Weight Heparin (LMWHs) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Low Molecular Weight Heparin (LMWHs) Consumption by Country (2017-2022)

    • Figure United States Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2017-2022)

    • Table Europe Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2017-2022)

    • Figure China Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2017-2022)

    • Figure Japan Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2017-2022)

    • Figure India Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Low Molecular Weight Heparin (LMWHs) Consumption and Growth Rate (2017-2022)

    • Figure Global Low Molecular Weight Heparin (LMWHs) Consumption Forecast by Country (2022-2028)

    • Figure United States Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Low Molecular Weight Heparin (LMWHs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enoxaparin Consumption and Growth Rate (2017-2022)

    • Figure Global Dalteparin Consumption and Growth Rate (2017-2022)

    • Figure Global Tinzaparin Consumption and Growth Rate (2017-2022)

    • Figure Global Fraxiparine Consumption and Growth Rate (2017-2022)

    • Figure Global Treatment of Venous Thromboembolism Consumption and Growth Rate (2017-2022)

    • Figure Global Complications of Pregnancy Consumption and Growth Rate (2017-2022)

    • Figure Global Cardioversion of Atrial Fibrillation/Flutter Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Enoxaparin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dalteparin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tinzaparin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fraxiparine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treatment of Venous Thromboembolism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Complications of Pregnancy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardioversion of Atrial Fibrillation/Flutter Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Low Molecular Weight Heparin (LMWHs) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Low Molecular Weight Heparin (LMWHs) Export by Region (Top 5 Countries) (2017-2028)

    • Table Opocrin (Foundation Year, Company Profile and etc.)

    • Table Opocrin Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opocrin Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Leo (Foundation Year, Company Profile and etc.)

    • Table Leo Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Leo Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Techdow (Foundation Year, Company Profile and etc.)

    • Table Techdow Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Techdow Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Amphastar (Foundation Year, Company Profile and etc.)

    • Table Amphastar Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amphastar Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Sandoz (Foundation Year, Company Profile and etc.)

    • Table Sandoz Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Glaxo Smith Kline (Foundation Year, Company Profile and etc.)

    • Table Glaxo Smith Kline Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxo Smith Kline Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table CSBIO (Foundation Year, Company Profile and etc.)

    • Table CSBIO Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSBIO Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Sanofi-aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-aventis Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Aspen (Foundation Year, Company Profile and etc.)

    • Table Aspen Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aspen Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Bioibérica (Foundation Year, Company Profile and etc.)

    • Table Bioibérica Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioibérica Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Low Molecular Weight Heparin (LMWHs) Product and Service

    • Table Intrapharm (Foundation Year, Company Profile and etc.)

    • Table Intrapharm Low Molecular Weight Heparin (LMWHs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intrapharm Low Molecular Weight Heparin (LMWHs) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US